| abstract |
EYE THERAPY USING AGENTS THAT ACTIVATE THE SIRTUINE. Ophthalmically therapeutic compositions, such as polymeric drug delivery systems, include a therapeutic component that includes an agent that activates sirtuin, such as resveratrol, which, upon release to the posterior segment of a mammal's eye, treats eye conditions. Methods of preparing and using the present compositions are also described. |